Biocon share price in focus on US FDA approval for cancer drug

featured-image

Biocon Share Price | The approval of JOBEVNE expands Biocon Biologics’ biosimilar oncology portfolio in the United States, which also includes OGIVRI (Trastuzumab-dkst) and FULPHILA (Pegfilgrastim-jmdb)..